René Russo
Chief Executive Officer bei XILIO THERAPEUTICS, INC.
Vermögen: 216 684 $ am 31.03.2024
Profil
René Russo, Gründer von Adagio Therapeutics, Inc. ist derzeit Chairman von Adagio Therapeutics, Inc. und President, Chief Executive Officer & Director bei Xilio Therapeutics, Inc. Dr. Russo ist auch Mitglied des Vorstands von Celsius Therapeutics, Inc. und X4 Pharmaceuticals, Inc. (ehemalige Präsidentin, Geschäftsführerin und Direktorin). In ihrer früheren Laufbahn war Dr. Russo Director bei Arsanis, Inc. und Vice President-Global Medical Affairs bei Cubist Pharmaceuticals LLC. René Russo hat an der Rutgers Business School promoviert und einen Bachelor-Abschluss erworben.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
XILIO THERAPEUTICS INC
0,73% | 01.01.2024 | 200 633 ( 0,73% ) | 216 684 $ | 31.03.2024 |
Aktive Positionen von René Russo
| Unternehmen | Position | Beginn |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Chief Executive Officer | 22.05.2019 |
Celsius Therapeutics, Inc.
 Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Director/Board Member | 01.05.2020 |
Xilio Therapeutics LLC
 Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Xilio Therapeutics, Inc., Xilio Therapeutics LLC develops cancer biopharmaceuticals. The private company is based in Waltham, MA. The CEO of the company is René Russo. | Chief Executive Officer | - |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | - |
| Life Science Cares, Inc. | Director/Board Member | - |
Leyden Labs
 Leyden Labs BiotechnologyHealth Technology Leyden Labs develops preventive medicines that target respiratory viruses. The private company is based in Leiden, Netherlands. | Director/Board Member | - |
Ehemalige bekannte Positionen von René Russo
| Unternehmen | Position | Ende |
|---|---|---|
| INVIVYD, INC. | Founder | 01.07.2022 |
| INVIVYD, INC. | Chairman | 01.06.2022 |
| X4 PHARMACEUTICALS, INC. | Chief Executive Officer | 26.11.2018 |
| ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von René Russo
| Rutgers Business School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| XILIO THERAPEUTICS, INC. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| INVIVYD, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Arsanis, Inc.
 Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Health Technology |
| Life Science Cares, Inc. | |
Xilio Therapeutics LLC
Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Xilio Therapeutics, Inc., Xilio Therapeutics LLC develops cancer biopharmaceuticals. The private company is based in Waltham, MA. The CEO of the company is René Russo. | Health Technology |
Leyden Labs
Leyden Labs BiotechnologyHealth Technology Leyden Labs develops preventive medicines that target respiratory viruses. The private company is based in Leiden, Netherlands. | Health Technology |
